These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34510451)

  • 81. Assessment of cellular mechanisms contributing to cAMP compartmentalization in pulmonary microvascular endothelial cells.
    Feinstein WP; Zhu B; Leavesley SJ; Sayner SL; Rich TC
    Am J Physiol Cell Physiol; 2012 Mar; 302(6):C839-52. PubMed ID: 22116306
    [TBL] [Abstract][Full Text] [Related]  

  • 82. cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies.
    Zaccolo M
    Br J Pharmacol; 2009 Sep; 158(1):50-60. PubMed ID: 19371331
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Phosphodiesterase 4D is required for beta2 adrenoceptor subtype-specific signaling in cardiac myocytes.
    Xiang Y; Naro F; Zoudilova M; Jin SL; Conti M; Kobilka B
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):909-14. PubMed ID: 15644445
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8).
    Georget M; Mateo P; Vandecasteele G; Lipskaia L; Defer N; Hanoune J; Hoerter J; Lugnier C; Fischmeister R
    FASEB J; 2003 Aug; 17(11):1380-91. PubMed ID: 12890691
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Selective inhibition of histamine-evoked Ca
    Dale P; Head V; Dowling MR; Taylor CW
    Cell Calcium; 2018 May; 71():53-64. PubMed ID: 29604964
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dynamics of adrenergic signaling in cardiac myocytes and implications for pharmacological treatment.
    Meyer EE; Clancy CE; Lewis TJ
    J Theor Biol; 2021 Jun; 519():110619. PubMed ID: 33740423
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effect of overexpressed adenylyl cyclase VI on beta 1- and beta 2-adrenoceptor responses in adult rat ventricular myocytes.
    Stark JC; Haydock SF; Foo R; Brown MJ; Harding SE
    Br J Pharmacol; 2004 Oct; 143(4):465-76. PubMed ID: 15381636
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Differential regulation of cardiac excitation-contraction coupling by cAMP phosphodiesterase subtypes.
    Mika D; Bobin P; Pomérance M; Lechêne P; Westenbroek RE; Catterall WA; Vandecasteele G; Leroy J; Fischmeister R
    Cardiovasc Res; 2013 Nov; 100(2):336-46. PubMed ID: 23933582
    [TBL] [Abstract][Full Text] [Related]  

  • 89. PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts.
    Meier S; Andressen KW; Aronsen JM; Sjaastad I; Hougen K; Skomedal T; Osnes JB; Qvigstad E; Levy FO; Moltzau LR
    Eur J Pharmacol; 2017 Oct; 812():174-183. PubMed ID: 28697992
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cyclic AMP synthesis and hydrolysis in the normal and failing heart.
    Guellich A; Mehel H; Fischmeister R
    Pflugers Arch; 2014 Jun; 466(6):1163-75. PubMed ID: 24756197
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway.
    Mongillo M; Tocchetti CG; Terrin A; Lissandron V; Cheung YF; Dostmann WR; Pozzan T; Kass DA; Paolocci N; Houslay MD; Zaccolo M
    Circ Res; 2006 Feb; 98(2):226-34. PubMed ID: 16357307
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Epac in cardiac calcium signaling.
    Ruiz-Hurtado G; Morel E; Domínguez-Rodríguez A; Llach A; Lezoualc'h F; Benitah JP; Gomez AM
    J Mol Cell Cardiol; 2013 May; 58():162-71. PubMed ID: 23220153
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure.
    Karam S; Margaria JP; Bourcier A; Mika D; Varin A; Bedioune I; Lindner M; Bouadjel K; Dessillons M; Gaudin F; Lefebvre F; Mateo P; Lechène P; Gomez S; Domergue V; Robert P; Coquard C; Algalarrondo V; Samuel JL; Michel JB; Charpentier F; Ghigo A; Hirsch E; Fischmeister R; Leroy J; Vandecasteele G
    Circulation; 2020 Jul; 142(2):161-174. PubMed ID: 32264695
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Palmitoylation regulates intracellular trafficking of β2 adrenergic receptor/arrestin/phosphodiesterase 4D complexes in cardiomyocytes.
    Liu R; Wang D; Shi Q; Fu Q; Hizon S; Xiang YK
    PLoS One; 2012; 7(8):e42658. PubMed ID: 22912718
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Mitochondrial A-kinase anchoring proteins in cardiac ventricular myocytes.
    Sherpa RT; Fiore C; Moshal KS; Wadsworth A; Rudokas MW; Agarwal SR; Harvey RD
    Physiol Rep; 2021 Sep; 9(17):e15015. PubMed ID: 34514737
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Intrinsic bias at non-canonical, β-arrestin-coupled seven transmembrane receptors.
    Pandey S; Kumari P; Baidya M; Kise R; Cao Y; Dwivedi-Agnihotri H; Banerjee R; Li XX; Cui CS; Lee JD; Kawakami K; Maharana J; Ranjan A; Chaturvedi M; Jhingan GD; Laporte SA; Woodruff TM; Inoue A; Shukla AK
    Mol Cell; 2021 Nov; 81(22):4605-4621.e11. PubMed ID: 34582793
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Protein-protein interaction network-based integration of GWAS and functional data for blood pressure regulation analysis.
    Tsare EG; Klapa MI; Moschonas NK
    Hum Genomics; 2024 Feb; 18(1):15. PubMed ID: 38326862
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Consecutive treatments of methamphetamine promote the development of cardiac pathological symptoms in zebrafish.
    Zhang J; Nguyen AH; Jilani D; Trigo Torres RS; Schmiess-Heine L; Le T; Xia X; Cao H
    PLoS One; 2023; 18(11):e0294322. PubMed ID: 37976248
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Evidence for a lack of inotropic and chronotropic effects of glucagon and glucagon receptors in the human heart.
    Aranda-Domene R; Orenes-Piñero E; Arribas-Leal JM; Canovas-Lopez S; Hernández-Cascales J
    Cardiovasc Diabetol; 2023 May; 22(1):128. PubMed ID: 37254135
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Inhibition of adenylyl cyclase 1 by ST034307 inhibits IP
    Bose SJ; Read MJ; Akerman E; Capel RA; Ayagama T; Russell A; Terrar DA; Zaccolo M; Burton RAB
    Front Pharmacol; 2022; 13():951897. PubMed ID: 36105228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.